FAP and breast carcinoma: One would expect to see complete normalization or a decrease of tracer uptake as a potential indicator of treatment response, as has been documented in neoadjuvant breast cancer treatment (16), although treatment may induce fibrosis which can lead to FAP uptake that confounds interpretation of treatment response.